SODIUM CHLORIDE 7%
(Hypertonic Saline 7%, NebuSal 7%, HyperSal 7%)Standard Prescription
hypertonic saline 7% mL by inhalation__(frequency) (prior to physiotherapy)
Dosages
Via Inhalation by Cystic Fibrosis patients and non-Cystic Fibrosis patients with bronchiectasis: 4 mL by inhalation BID prior to physiotherapy.
May be increased to TID if needed.
(Dose is reduced to 2.5-3 mL for the eFlow Altera Nebulizer System due to
the efficiency of this nebulizer [not a hospital-supplied device; patients may use their own device])
May be increased to TID if needed.
(Dose is reduced to 2.5-3 mL for the eFlow Altera Nebulizer System due to
the efficiency of this nebulizer [not a hospital-supplied device; patients may use their own device])
Mechanism of Action
Mucoactive agent
Forms Supplied
Ampoule for Inhalation: 7% Sodium Chloride in 4 mL ampoule
Comments
Approved only for use by Cystic Fibrosis patients and non-Cystic Fibrosis patients with bronchiectasis to help clear mucous secretions or to induce sputum production.
Prescribing is limited to Respiratory Medicine.
May cause bronchospasm: must be administered with or immediately after a bronchodilator.
Refer to nursing guidelines: Using hypertonic saline in patients with Cystic Fibrosis in PHSA SHOP.
References
307, 654
Last Edited
2022-09-12 05:23:02